Osteoarthritis News and Research

Latest Osteoarthritis News and Research

OrthoTrophix commences TPX-100 Phase 2 clinical study in knee osteoarthritis patients

OrthoTrophix, Inc., a privately held biopharmaceutical company, announced today that the Company started a Phase 2 clinical study of its cartilage repair therapeutic agent, TPX-100, with knee osteoarthritis patients in the U.S. The Company also announced that it had successfully closed the second and last tranche of its Series A preferred stock financing.

20 Feb 2014

Ways to help manage chronic pain

Musculoskeletal pain of the bone, joint and muscles is one of the most common reasons for primary care visits in the United States. According to a literature review appearing in a recent issue of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS), chronic pain, or pain that persists beyond an expected period of healing, is estimated to affect 100 million Americans.

20 Feb 2014

Researchers examine link between non-restorative sleep and widespread pain among older adults

Researchers in the U.K. report that non-restorative sleep is the strongest, independent predictor of widespread pain onset among adults over the age of 50. According to the study published in Arthritis & Rheumatology (formerly Arthritis & Rheumatism), a journal of the American College of Rheumatology (ACR), anxiety, memory impairment, and poor physical health among older adults may also increase the risk of developing widespread pain.

13 Feb 2014

Mallinckrodt announces commercial launch of PENNSAID

Mallinckrodt today announced the commercial launch of PENNSAID (diclofenac sodium topical solution) 2% w/w (PENNSAID 2%). PENNSAID 2% is a topical non-steroidal anti-inflammatory drug (NSAID) approved for use in the treatment of the pain of osteoarthritis of the knees.

10 Feb 2014

Spinifex announces results of Phase 2 clinical trial of EMA401 in postherpetic neuralgia

Spinifex Pharmaceuticals, an Australian pain drug development company, today announces that The Lancet has published the results of its Phase 2 clinical trial of its lead candidate, EMA401, in postherpetic neuralgia (PHN).

5 Feb 2014

New drug treatment effective against chronic pain caused by nerve damage post shingles

A new drug treatment has been found to be effective against chronic pain caused by nerve damage, also known as neuropathic pain, in patients who have had shingles.

5 Feb 2014

Scientists receive new awards from CIRM to advance revolutionary stem cell science in medicine

Scientists from UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have received new awards from the California Institute of Regenerative Medicine (CIRM), the state stem cell research agency, that will forward revolutionary stem cell science in medicine.

30 Jan 2014

Tufts Medical Center receives funds to develop mathematical models to identify patients for clinical trials

A Tufts Medical Center research team at the Institute for Clinical Research and Health Policy Studies (ICRHPS) has been approved for a funding award by the Patient-Centered Outcomes Research Institute (PCORI) to develop a method for patient-centered enrollment in comparative effectiveness trials called Mathematical Equipoise.

28 Jan 2014

Researchers locate two molecules involved in perpetuating chronic pain

Setting the stage for possible advances in pain treatment, researchers at The Johns Hopkins University and the University of Maryland report they have pinpointed two molecules involved in perpetuating chronic pain in mice. The molecules, they say, also appear to have a role in the phenomenon that causes uninjured areas of the body to be more sensitive to pain when an area nearby has been hurt.

24 Jan 2014

Bariatric surgeon educates patients about bariatric surgeries to achieve healthy weight

While many Americans make New Year's resolutions focused on self-improvement, those who are overweight or obese likely prioritize getting down to a healthy weight.

21 Jan 2014

FDA approves New Drug Application for PENNSA 2%

Mallinckrodt today announced that the U.S. Food and Drug Administration has approved the New Drug Application for PENNSAID (diclofenac sodium topical solution) 2% w/w. PENNSAID 2% is a topical non-steroidal anti-inflammatory drug approved for use in the treatment of the pain of osteoarthritis of the knee(s).

17 Jan 2014

Single stem cell injection after meniscus knee surgery may provide pain relief, aid in meniscus regrowth

A single stem cell injection following meniscus knee surgery may provide pain relief and aid in meniscus regrowth, according to a novel study appearing in the January issue of the Journal of Bone and Joint Surgery (JBJS).

17 Jan 2014

Researchers develop "smart" hydrogel that can deliver medicine on demand

Researchers at the University of Delaware have developed a "smart" hydrogel that can deliver medicine on demand, in response to mechanical force.

16 Jan 2014

FDA accepts Iroko Pharmaceuticals' ZORVOLEX sNDA for review

Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced that the U.S. Food and Drug Administration has accepted for review the Supplemental New Drug Application for ZORVOLEX (diclofenac), a lower dose nonsteroidal anti-inflammatory drug, for the proposed indication of treatment of osteoarthritis pain in adults. ZORVOLEX was approved by FDA in October 2013 for the treatment of mild to moderate acute pain in adults.

15 Jan 2014

Synthetic cannabinoid molecule created for osteoarthritis

Chemical compounds synthesised in the laboratory, similar to those found in cannabis, could be developed as potential drugs to reduce the pain of osteoarthritis.

7 Jan 2014

UC Davis docs find a way to create "movies" of wrist in motion using magnetic resonance imaging scans

If a picture is worth 1,000 words then a movie is worth far more, especially when it comes to diagnosing wrist problems.

3 Jan 2014

Personalized asthma strategies needed to tackle comorbidities

Results from a German national health survey indicate that asthma patients with multiple comorbidities are at increased risk for unplanned hospital admissions.

31 Dec 2013

FIDELITY project compares surgical treatment of degenerative meniscal tears to placebo surgery

The Finnish Degenerative Meniscal Lesion Study (FIDELITY) compared surgical treatment of degenerative meniscal tears to placebo surgery.

27 Dec 2013

Surgeons at French hospital perform first Navio UKR procedures

Blue Belt Technologies announces the first Navio™ unicondylar knee replacement (UKR) procedures performed in France, completed on September 30th, October 15th and Nov 4th 2013 by Professor Philippe Neyret and Dr. Sébastien Lustig at Hospices Civils de Lyon in France.

23 Dec 2013

Nuvo Research, NovaMedica enter into agreement to market Pennsaid products in Russia

Nuvo Research Inc., a specialty pharmaceutical company with a diverse portfolio of products in the areas of topical pain and immunology, and NovaMedica LLC, a Russian pharmaceutical company, today announced that they have signed a supply and distribution agreement providing NovaMedica the exclusive rights to market and sell Nuvo's Pennsaid 1.5% and Pennsaid 2% products in Russia and some of the Community of Independent States.

19 Dec 2013

Osteoarthritis News and Research

Latest Osteoarthritis News and Research

OrthoTrophix commences TPX-100 Phase 2 clinical study in knee osteoarthritis patients

Ways to help manage chronic pain

Researchers examine link between non-restorative sleep and widespread pain among older adults

Mallinckrodt announces commercial launch of PENNSAID

Spinifex announces results of Phase 2 clinical trial of EMA401 in postherpetic neuralgia

New drug treatment effective against chronic pain caused by nerve damage post shingles

Scientists receive new awards from CIRM to advance revolutionary stem cell science in medicine

Tufts Medical Center receives funds to develop mathematical models to identify patients for clinical trials

Researchers locate two molecules involved in perpetuating chronic pain

Bariatric surgeon educates patients about bariatric surgeries to achieve healthy weight

FDA approves New Drug Application for PENNSA 2%

Single stem cell injection after meniscus knee surgery may provide pain relief, aid in meniscus regrowth

Researchers develop "smart" hydrogel that can deliver medicine on demand

FDA accepts Iroko Pharmaceuticals' ZORVOLEX sNDA for review

Synthetic cannabinoid molecule created for osteoarthritis

UC Davis docs find a way to create "movies" of wrist in motion using magnetic resonance imaging scans

Personalized asthma strategies needed to tackle comorbidities

FIDELITY project compares surgical treatment of degenerative meniscal tears to placebo surgery

Surgeons at French hospital perform first Navio UKR procedures

Nuvo Research, NovaMedica enter into agreement to market Pennsaid products in Russia

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Osteoarthritis News and Research

Latest Osteoarthritis News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in